O-022 A Randomized, Double-Blind, Multicenter Phase 3 Study of Brivanib versus Placebo as Adjuvant Therapy to Trans-Arterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Initial Results


M. Kudo, R. Finn, R. Poon, J.-F. Blanc, G. Han, L. Yan, J. Yang, L. Lu, W. Y. Tak, X. Yu, J.H. Lee, S.-M. Lin, C. Wu, T. Tanwandee, G. Shao, I. Walters, C. Dela Cruz, V. Poulart, J. H. Wang